Page last updated: 2024-11-03

pyrimethamine and Anemia

pyrimethamine has been researched along with Anemia in 121 studies

Maloprim: contains above 2 cpds

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research Excerpts

ExcerptRelevanceReference
"Coverage of antenatal iron and folic acid (IFA) supplementation and malaria chemoprophylaxis remains low in many low-income and middle-income settings."9.69Improving coverage of antenatal iron and folic acid supplementation and malaria prophylaxis through targeted information and home deliveries in Côte d'Ivoire: a cluster randomised controlled trial. ( Dao, D; Fink, G; Koné, S; Probst-Hensch, N; Utzinger, J, 2023)
"In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester."9.15Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. ( Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS, 2011)
"In the context of a trial studying intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Lambaréné, Gabon, children aged 18-30 months were followed up after having received their last dose at an age of 15 months."9.14No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. ( Aponte, JJ; Borchert, LB; Doernemann, J; Gabor, JJ; Grobusch, MP; Issifou, S; Koester, KB; Kremsner, PG; Kurth, F; Lell, B; Poetschke, M; Pongratz, P; Profanter, K; Schuster, K; Schwarz, NG, 2009)
"The study design was an open randomized control trial comparing anaemia incidence among pregnant women on intermittent presumptive treatment of malaria with SP with those on chloroquine (CQ)."9.13Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women. ( Abiona, TC; Asa, OO; Fatusi, AO; Ijadunola, KT; Onayade, AA, 2008)
"Whether administration of folic acid to children with malaria anemia is helpful is controversial."9.12Folic acid treatment of Zambian children with moderate to severe malaria anemia. ( Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P, 2006)
" We tested the hypothesis that artesunate-sulfamethoxypyrazine-pyrimethamine is as efficacious as the four-dose regimen of artemether-lumefantrine for treatment of Plasmodium falciparum malaria."9.12A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. ( Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y, 2006)
"The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp)."9.12Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007)
"The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa."8.98Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018)
"In 2012 the World Health Organisation (WHO) revised the policy on Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) to at least three doses for improved protection against malaria parasitaemia and its associated effects such as anaemia during pregnancy."8.02Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study. ( Agyeman, YN; Annor, RB; Newton, S; Owusu-Dabo, E, 2021)
" Structured interview and antenatal clinic cards were used to obtain data including the use of intermittent preventive therapy in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)."7.91Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. ( Aklillu, E; Kamuhabwa, AAR; Mikomangwa, WP; Oms, M, 2019)
"To investigate whether high-dosed folate supplements might diminish the efficacy of malaria intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) in a cohort of pregnant women in Benin, where malaria is holoendemic."7.88High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin. ( Accrombessi, M; Cot, M; Moya-Alvarez, V; Ouédraogo, S, 2018)
"The impact of sulfadoxine-pyrimethamine (SP) used as intermittent preventive treatment during pregnancy (IPTp-SP) on mutant parasite selection has been poorly documented in Burkina Faso."7.85Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. ( Awandare, GA; Cisse, M; Guiguemdé, RT; Hayette, MP; Soulama, A; Tinto, H, 2017)
"Effectiveness of cotrimoxazole (CTX) compared with sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp) for malaria in HIV-infected pregnant women is unknown."7.77Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. ( Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB, 2011)
"To assess the effect of intermittent preventive treatment with sulfadoxine and pyrimethamine (IPT-SP) on placental parasitemia and maternal and perinatal outcome."7.77Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria. ( Akubuo, KK; Aziken, ME; Gharoro, EP, 2011)
"The effectiveness of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) against malaria and anemia is unclear because of the spread of SP-resistant Plasmodium falciparum."7.77Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. ( Adjei, AA; Anderson, WA; Ceesay, FK; Gyasi, RK; Lucchi, NW; Ndjakani, Y; Obed, SA; Rodney, P; Stiles, JK; Wilson, NO, 2011)
"To evaluate the impact of a 2-year programme for community-based delivery of sulfadoxine-pyrimethamine (SP) on intermittent preventive treatment during pregnancy coverage, antenatal clinic attendance and pregnancy outcome."7.75Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, PN; Msyamboza, KP; Savage, EJ, 2009)
"To appraise the prevalence of malaria and anaemia in antenatal mothers; and explore the factors influencing coverage of intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) under operational conditions in the national programme for malaria control in pregnancy."7.74Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania. ( Tarimo, SD, 2007)
"In 1993, Malawi introduced sulphadoxine-pyrimethamine (SP) for the treatment of uncomplicated, Plasmodium falciparum malaria and became the first country in Africa to abandon chloroquine for first-time therapy."7.69Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. ( Brabin, BJ; Kachale, B; Kazembe, P; Masache, P; Van der Kaay, HJ; Verhoeff, FH, 1997)
"Intermittent preventive treatment of malaria among schoolchildren (IPTsc) reduces clinical malaria, asymptomatic parasitemia, and anemia."7.11Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial. ( Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI, 2022)
"Coverage of antenatal iron and folic acid (IFA) supplementation and malaria chemoprophylaxis remains low in many low-income and middle-income settings."5.69Improving coverage of antenatal iron and folic acid supplementation and malaria prophylaxis through targeted information and home deliveries in Côte d'Ivoire: a cluster randomised controlled trial. ( Dao, D; Fink, G; Koné, S; Probst-Hensch, N; Utzinger, J, 2023)
" There was significant association between gravidity and SP dosage taken (Pearson χ2 = 18."5.37The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana. ( Browne, E; Lawson, B; Tutu, EO, 2011)
"Intermittent preventive treatment of malaria in infants (IPTi) consists of the administration of a treatment dose of sulphadoxine-pyrimethamine (SP) at the time of routine vaccinations."5.15Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania. ( Alonso, P; Armstrong Schellenberg, JR; Chemba, M; Maokola, W; Mshinda, H; Schellenberg, D; Shirima, K; Tanner, M; Willey, BA, 2011)
"In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester."5.15Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. ( Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS, 2011)
"During the 2003 and 2004 malaria transmission seasons, 1200 Gambian children with moderate or severe anaemia (Hb concentration <7 g/dL) were randomised to receive either monthly sulfadoxine-pyrimethamine (SP) or placebo until the end of the malaria transmission season in which they were enrolled, in a double-blind trial."5.14Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. ( Abubakr, I; Bojang, KA; Conway, DJ; Greenwood, B; Jallow, M; Milligan, PJ; Njie, F; Nwakanma, DC; Sisay-Joof, F, 2010)
"Between March 2004 and March 2008, in an area of western Kenya with year round malaria transmission with high seasonal intensity and high usage of insecticide-treated nets, we conducted a randomized, double-blind placebo-controlled trial with SP plus 3 days of artesunate (SP-AS3), 3 days of amodiaquine-artesunate (AQ3-AS3), or 3 days of short-acting chlorproguanil-dapsone (CD3) administered at routine expanded programme of immunization visits (10 weeks, 14 weeks and 9 months)."5.14Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial. ( Hamel, MJ; Kariuki, S; Lindblade, K; Newman, RD; Odhiambo, FO; Otieno, P; Peterson, E; Slutsker, L; ter Kuile, FO; Vulule, J; Williamson, J, 2010)
"In the context of a trial studying intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Lambaréné, Gabon, children aged 18-30 months were followed up after having received their last dose at an age of 15 months."5.14No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. ( Aponte, JJ; Borchert, LB; Doernemann, J; Gabor, JJ; Grobusch, MP; Issifou, S; Koester, KB; Kremsner, PG; Kurth, F; Lell, B; Poetschke, M; Pongratz, P; Profanter, K; Schuster, K; Schwarz, NG, 2009)
"The use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) is threatened by the spread of resistance to SP."5.13A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. ( Affipunguh, PK; Bruce, J; Chandramohan, D; Clerk, CA; Greenwood, B; Hodgson, A; Mensah, N, 2008)
"Monthly artesunate plus amodiaquine reduced the incidence of malaria by 69% (95% CI: 63%, 74%) and anaemia by 45% (95% CI: 25%,60%), bimonthly sulphadoxine-pyrimethamine reduced the incidence of malaria by 24% (95% CI: 14%,33%) and anaemia by 30% (95% CI: 6%, 49%) and bimonthly artesunate plus amodiaquine reduced the incidence of malaria by 17% (95% CI: 6%, 27%) and anaemia by 32% (95% CI: 7%, 50%) compared to placebo."5.13Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. ( Adjuik, M; Binka, F; Chandramohan, D; Greenwood, B; Kweku, M; Liu, D; Seidu, M, 2008)
"The main objective of the study was to assess the impact of a community-based delivery system of intermittent preventive treatment (IPT) for malaria in pregnancy with sulfadoxine-pyrimethamine (SP) on access, parasitemia, anemia and low birth weight as primary outcome measures."5.13Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda. ( Bygbjerg, I; Magnussen, P; Mbonye, AK, 2008)
"Intermittent preventive treatment with three doses of sulfadoxine-pyrimethamine is a more effective strategy to prevent maternal anemia during pregnancy in Burkina Faso."5.13[Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso]. ( Bougouma, EC; Diarra, A; Konaté, AT; Nébié, I; Ouédraogo, A; Sirima, SB; Tiono, AB, 2008)
"The study design was an open randomized control trial comparing anaemia incidence among pregnant women on intermittent presumptive treatment of malaria with SP with those on chloroquine (CQ)."5.13Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women. ( Abiona, TC; Asa, OO; Fatusi, AO; Ijadunola, KT; Onayade, AA, 2008)
"Whether administration of folic acid to children with malaria anemia is helpful is controversial."5.12Folic acid treatment of Zambian children with moderate to severe malaria anemia. ( Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P, 2006)
" We tested the hypothesis that artesunate-sulfamethoxypyrazine-pyrimethamine is as efficacious as the four-dose regimen of artemether-lumefantrine for treatment of Plasmodium falciparum malaria."5.12A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. ( Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y, 2006)
" The purpose was to compare the efficacy of two regimens using chloroquine (CQ) or sulfadoxine-pyrimethamine (SP) during pregnancy and delivery in a village located in an endemic area of Mali."5.12[Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali]. ( Dabo, CA; Diallo, M; Diarra, MA; Doumbo, O; Kayentao, K; Ongoiba, A; Sangho, H; Saye, R; Yattara, O, 2007)
"The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp)."5.12Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007)
"We investigated the ability of intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine/pyrimethamine to prevent anaemia and low birthweight in Gambian multigravidae."5.12A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. ( Balajo, B; Dunyo, S; Greenwood, B; Mbaye, A; Milligan, P; Richardson, K; Shulman, C; Walraven, G, 2006)
"Intermittent preventive treatment for malaria with sulfadoxine-pyrimethamine can reduce malaria and anaemia in infants even in seasonal, high transmission areas, but concern exists about possible rebound in the incidence of malaria in the second year of life."5.11Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. ( Amponsa-Achiano, K; Awine, T; Baiden, R; Binka, F; Carneiro, I; Chandramohan, D; Greenwood, B; Hodgson, A; Jaffar, S; Mensah, N; Owusu-Agyei, S, 2005)
"In Mali, IPT with SP appears more efficacious than weekly chloroquine chemoprophylaxis in preventing malaria during pregnancy."5.11Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. ( Coulibaly, D; Doumbo, O; Doumtabe, D; Kayentao, K; Keita, AS; Kodio, M; Maiga, B; Maiga, H; Mungai, M; Newman, RD; Ongoiba, A; Parise, ME, 2005)
"The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa."4.98Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018)
"In 2012, WHO changed its recommendation for intermittent preventive treatment of malaria during pregnancy (IPTp) from two doses to monthly doses of sulfadoxine-pyrimethamine during the second and third trimesters, but noted the importance of a cost-effectiveness analysis to lend support to the decision of policy makers."4.91Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data. ( Akazili, J; Fernandes, S; Hanson, K; Hill, J; Kayentao, K; Madanitsa, M; Sicuri, E; ter Kuile, FO; van Eijk, AM; Webster, J; Were, V, 2015)
"In 2012 the World Health Organisation (WHO) revised the policy on Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) to at least three doses for improved protection against malaria parasitaemia and its associated effects such as anaemia during pregnancy."4.02Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study. ( Agyeman, YN; Annor, RB; Newton, S; Owusu-Dabo, E, 2021)
" Structured interview and antenatal clinic cards were used to obtain data including the use of intermittent preventive therapy in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)."3.91Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. ( Aklillu, E; Kamuhabwa, AAR; Mikomangwa, WP; Oms, M, 2019)
"To investigate whether high-dosed folate supplements might diminish the efficacy of malaria intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) in a cohort of pregnant women in Benin, where malaria is holoendemic."3.88High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin. ( Accrombessi, M; Cot, M; Moya-Alvarez, V; Ouédraogo, S, 2018)
"The impact of sulfadoxine-pyrimethamine (SP) used as intermittent preventive treatment during pregnancy (IPTp-SP) on mutant parasite selection has been poorly documented in Burkina Faso."3.85Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. ( Awandare, GA; Cisse, M; Guiguemdé, RT; Hayette, MP; Soulama, A; Tinto, H, 2017)
"Six years after the implementation of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) in Gabon, its impact on placental malaria and pregnancy outcomes remains unknown."3.83Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon. ( Ambounda, N; Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Mawili-Mboumba, DP; Moutandou Chiesa, S; Tshibola Mbuyi, ML; Tsoumbou-Bakana, G; Zong, J, 2016)
"The effectiveness of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) against malaria and anemia is unclear because of the spread of SP-resistant Plasmodium falciparum."3.77Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. ( Adjei, AA; Anderson, WA; Ceesay, FK; Gyasi, RK; Lucchi, NW; Ndjakani, Y; Obed, SA; Rodney, P; Stiles, JK; Wilson, NO, 2011)
"To assess the effect of intermittent preventive treatment with sulfadoxine and pyrimethamine (IPT-SP) on placental parasitemia and maternal and perinatal outcome."3.77Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria. ( Akubuo, KK; Aziken, ME; Gharoro, EP, 2011)
"Effectiveness of cotrimoxazole (CTX) compared with sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp) for malaria in HIV-infected pregnant women is unknown."3.77Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. ( Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB, 2011)
"Data on antenatal attendance, uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), birthweight, malaria, anaemia, for 2,152 primigravidae."3.76Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, P; Msyamboza, K; Savage, E, 2010)
"To evaluate the impact of a 2-year programme for community-based delivery of sulfadoxine-pyrimethamine (SP) on intermittent preventive treatment during pregnancy coverage, antenatal clinic attendance and pregnancy outcome."3.75Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, PN; Msyamboza, KP; Savage, EJ, 2009)
"To appraise the prevalence of malaria and anaemia in antenatal mothers; and explore the factors influencing coverage of intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) under operational conditions in the national programme for malaria control in pregnancy."3.74Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania. ( Tarimo, SD, 2007)
"Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) has been adopted as policy by many countries in sub-Saharan Africa."3.74Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. ( Acquah, PA; Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C, 2007)
"Anaemia [haemoglobin (Hb) <11 g/dl), severe anaemia (Hb <8 g/dl) and placental malaria were compared among women with known HIV status who delivered at a provincial hospital after study enrolment in the third trimester during three consecutive periods: period 1, no routine intervention (reference); period 2, routine haematinic supplementation (60 mg elementary iron three times/day, folic acid 5 mg once daily) and period 3, haematinics and IPT with SP."3.74Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya. ( Ayisi, JG; Kager, PA; Nahlen, BL; Otieno, JA; Rosen, DH; Shi, YP; Slutsker, L; Steketee, RW; Ter Kuile, FO; van Eijk, AM, 2007)
"Febrile adults with Plasmodium falciparum parasitemia were treated with sulfadoxine-pyrimethamine and were monitored for 28 days."3.73HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya. ( Bloland, PB; Hamel, MJ; Kain, KC; Obonyo, CO; Shah, SN; Slutsker, L; Smith, EE, 2006)
"To reduce the intolerable burden of malaria in pregnancy, the Ministry of Health in Tanzania has recently adopted a policy of intermittent presumptive treatment for pregnant women using sulphadoxine-pyrimethamine (IPTp-SP)."3.72Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. ( Drakeley, C; Marchant, T; Nganda, RY; Reyburn, H, 2004)
"The study population consisted of 26 Zambian children < 6 years of age who presented with cerebral malaria to a rural hospital in 1994 and who were treated with quinine for seven days."3.70Prolonged macrophage activation and persistent anaemia in children with complicated malaria. ( Biemba, G; Gordeuk, VR; Mabeza, GF; Thuma, PE; Weiss, G, 1998)
"In 1993, Malawi introduced sulphadoxine-pyrimethamine (SP) for the treatment of uncomplicated, Plasmodium falciparum malaria and became the first country in Africa to abandon chloroquine for first-time therapy."3.69Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. ( Brabin, BJ; Kachale, B; Kazembe, P; Masache, P; Van der Kaay, HJ; Verhoeff, FH, 1997)
"Intermittent preventive treatment of malaria among schoolchildren (IPTsc) reduces clinical malaria, asymptomatic parasitemia, and anemia."3.11Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial. ( Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI, 2022)
"In endemic areas, malaria and its adverse effects in schoolchildren may be prevented by intermittent preventive treatment (IPTsc)."2.84Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial. ( da Luz, RI; Doua, JY; Lutumba, P; Matangila, JR; Mitashi, P; Van Geertruyden, JP, 2017)
"Asymptomatic falciparum malaria is associated with poorer cognitive performance in African schoolchildren and intermittent preventive treatment of malaria improves cognitive outcomes."2.82Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children. ( Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A, 2016)
" CF fortified with highly bioavailable iron improved iron status but not Hb concentration, despite three-monthly IPT of malaria."2.80The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial. ( Adiossan, LG; Brittenham, GM; Diakité, VG; Glinz, D; Hurrell, RF; N'Goran, EK; Ouattara, M; Righetti, AA; Seifert, B; Utzinger, J; Wegmüller, R; Zimmermann, MB, 2015)
"Intermittent preventive treatment for malaria in children (IPTc) involves the administration of a full course of an anti-malarial treatment to children under 5 years old at specified time points regardless of whether or not they are known to be infected, in areas where malaria transmission is seasonal."2.75Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. ( Chandramohan, D; Conteh, L; Greenwood, B; Kweku, M; Legood, R; Patouillard, E, 2010)
" However, the optimal dosing regimen in settings in which human immunodeficiency virus (HIV) is highly prevalent among pregnant women remains controversial."2.73Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mubikayi, L; Mukwamataba, D; Mulele, CK; Mulenga, M; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007)
"Malaria was an important risk factor for any and moderate anaemia; use of an insecticide-treated net (ITN) was a protective factor for any anaemia."2.73Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya. ( Ayisi, JG; Hamel, MJ; Kager, PA; Otieno, K; Ouma, P; Parise, M; Slutsker, L; van Eijk, AM, 2007)
"Intermittent preventive treatment for malaria in Infants (IPTi) has been shown to give effective and safe protection against malaria."2.73Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. ( Awine, T; Cairns, M; Carneiro, I; Chandramohan, D; Gosling, R; Greenwood, B; Milligan, P; Owusu-Agyei, S, 2008)
"Malaria in pregnancy is a significant contributor to adverse pregnancy outcome, especially in Sub-Saharan Africa."2.49A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. ( Dent, AE; Goldenberg, RL; McClure, EM; Meshnick, SR, 2013)
"IPTi with sulfadoxine-pyrimethamine was safe and efficacious across a range of malaria transmission settings, suggesting that this intervention is a useful contribution to malaria control."2.45Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. ( Adjei, S; Alonso, P; Anemana, S; Aponte, JJ; Breckenridge, A; Carneiro, I; Chandramohan, D; Critchley, J; Danquah, I; Dodoo, A; Egan, A; Greenwood, B; Grobusch, MP; Issifou, S; Kobbe, R; Kremsner, PG; Lell, B; Macete, E; May, J; Menendez, C; Mockenhaupt, F; Mshinda, H; Newman, RD; Owusu-Agyei, S; Premji, Z; Sanz, S; Schellenberg, D; Sevene, E; Slutsker, L; Soulaymani-Becheikh, R; Tanner, M; Winstanley, P, 2009)
"Severe anaemia in pregnancy is an important contributor to maternal and perinatal morbidity and mortality."2.40Malaria in pregnancy: its relevance to safe-motherhood programmes. ( Shulman, CE, 1999)
"Malaria in pregnancy is an immense public health problem with at least 50 million pregnant women living in malaria endemic areas."1.43Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon. ( Anchang-Kimbi, JK; Fokam, EB; Ngimuh, L; Wanji, S, 2016)
" There was significant association between gravidity and SP dosage taken (Pearson χ2 = 18."1.37The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana. ( Browne, E; Lawson, B; Tutu, EO, 2011)
"Severe malaria has been neglected as a subject for clinical investigation, and there is little information available on which to base rational treatment."1.27Management of Plasmodium falciparum malaria. ( Phillips, RE, 1984)

Research

Studies (121)

TimeframeStudies, this research(%)All Research%
pre-199018 (14.88)18.7374
1990's5 (4.13)18.2507
2000's50 (41.32)29.6817
2010's40 (33.06)24.3611
2020's8 (6.61)2.80

Authors

AuthorsStudies
Woodruff, AW1
Ahadzie-Soglie, A1
Addai-Mensah, O1
Abaka-Yawson, A1
Setroame, AM1
Kwadzokpui, PK1
Maiga, H3
Opondo, C1
Chico, RM1
Cohee, LM1
Sagara, I2
Traore, OB2
Tekete, M2
Dara, A4
Traore, ZI2
Diarra, M1
Coumare, S1
Kodio, A1
Bamadio, A1
Sidibe, B1
Doumbo, OK6
Djimde, AA2
Ampofo, GD1
Osarfo, J1
Aberese-Ako, M1
Asem, L1
Komey, MN1
Mohammed, W1
Ofosu, AA1
Tagbor, H1
Crider, K1
Williams, J1
Qi, YP1
Gutman, J1
Yeung, L1
Mai, C1
Finkelstain, J1
Mehta, S1
Pons-Duran, C2
Menéndez, C5
Moraleda, C1
Rogers, L1
Daniels, K1
Green, P1
Uwimana, A1
Sethi, R1
Murindahabi, M1
Ntirandeka, C1
Piercefield, E1
Umulisa, N1
Abram, A1
Eckert, E1
Munguti, K1
Sullivan, D1
Uyizeye, D1
Mbituyumuremyi, A1
Gutman, JR1
Koné, S1
Probst-Hensch, N1
Dao, D1
Utzinger, J2
Fink, G1
Anabire, NG1
Aculley, B1
Pobee, A1
Kyei-Baafour, E1
Awandare, GA2
Del Pilar Quintana, M1
Hviid, L1
Ofori, MF1
Unger, HW1
Rosanas-Urgell, A1
Robinson, LJ1
Ome-Kaius, M1
Jally, S1
Umbers, AJ1
Pomat, W1
Mueller, I1
Kattenberg, E1
Rogerson, SJ1
Agyeman, YN1
Newton, S1
Annor, RB1
Owusu-Dabo, E1
Moya-Alvarez, V1
Ouédraogo, S1
Accrombessi, M1
Cot, M2
González, R1
Piqueras, M1
Aponte, JJ4
Ter Kuile, FO9
Mikomangwa, WP1
Oms, M1
Aklillu, E1
Kamuhabwa, AAR1
McClure, EM1
Goldenberg, RL1
Dent, AE1
Meshnick, SR3
Doumbo, S2
Ongoiba, OA1
Doumtabé, D3
Ouologuem, TD1
Kayentao, K5
Djimdé, A3
Traoré, B2
Aguilar, R1
Marrocco, T1
Skorokhod, OA1
Barbosa, A1
Nhabomba, A1
Manaca, MN1
Guinovart, C1
Quintó, L1
Arese, P1
Alonso, PL2
Dobaño, C1
Schwarzer, E1
Valea, I2
Tinto, H4
Drabo, MK2
Huybregts, L2
Henry, MC1
Roberfroid, D1
Guiguemde, RT4
Kolsteren, P2
D'Alessandro, U7
Mosha, D1
Chilongola, J1
Ndeserua, R1
Mwingira, F1
Genton, B1
Cisse, M2
Sangare, I1
Lougue, G1
Bamba, S1
Bayane, D1
Fernandes, S1
Sicuri, E1
van Eijk, AM4
Hill, J1
Webster, J1
Were, V1
Akazili, J1
Madanitsa, M1
Hanson, K1
Briand, V1
Escolano, S1
Journot, V1
Massougbodji, A2
Tubert-Bitter, P1
Glinz, D1
Hurrell, RF1
Ouattara, M1
Zimmermann, MB1
Brittenham, GM1
Adiossan, LG1
Righetti, AA1
Seifert, B1
Diakité, VG1
N'Goran, EK1
Wegmüller, R1
Fokam, EB1
Ngimuh, L1
Anchang-Kimbi, JK1
Wanji, S1
Boivin, MJ1
Sikorskii, A1
Familiar-Lopez, I1
Ruiseñor-Escudero, H1
Muhindo, M1
Kapisi, J1
Bigira, V1
Bass, JK1
Opoka, RO1
Nakasujja, N1
Kamya, M1
Dorsey, G1
Bouyou-Akotet, MK2
Mawili-Mboumba, DP1
Kendjo, E2
Moutandou Chiesa, S1
Tshibola Mbuyi, ML1
Tsoumbou-Bakana, G1
Zong, J1
Ambounda, N1
Kombila, M2
Matangila, JR1
Doua, JY1
Mitashi, P1
da Luz, RI1
Lutumba, P1
Van Geertruyden, JP2
Soulama, A1
Hayette, MP1
Mbonye, AK2
Hansen, KS1
Bygbjerg, IC2
Magnussen, P3
Clarke, SE2
Jukes, MC2
Njagi, JK2
Khasakhala, L1
Cundill, B1
Otido, J1
Crudder, C1
Estambale, BB2
Brooker, S2
Naniche, D1
Lahuerta, M1
Bardaji, A1
Sigauque, B1
Romagosa, C1
Berenguera, A1
Mandomando, I1
David, C1
Sanz, S2
Aponte, J1
Ordi, J1
Alonso, P4
Clerk, CA1
Bruce, J1
Affipunguh, PK1
Mensah, N2
Hodgson, A3
Greenwood, B11
Chandramohan, D8
Manzi, F1
Schellenberg, J1
Hamis, Y1
Mushi, AK1
Shirima, K2
Mwita, A1
Simba, A1
Rusibamayila, N1
Kitambi, M1
Tanner, M4
Mshinda, H4
Schellenberg, D4
Temperley, M1
Mueller, DH1
Akhwale, W1
Kweku, M2
Liu, D1
Adjuik, M2
Binka, F2
Seidu, M1
Billal, DS1
Hotomi, M1
Yamanaka, N1
Gies, S3
Coulibaly, SO2
Ouattara, FT1
Msyamboza, KP1
Savage, EJ1
Kazembe, PN1
Kalanda, G2
Brabin, BJ3
Barger, B1
Tembine, I2
Gantt, S1
Egan, A1
Breckenridge, A1
Carneiro, I3
Critchley, J1
Danquah, I2
Dodoo, A1
Kobbe, R1
Lell, B3
May, J1
Premji, Z1
Sevene, E1
Soulaymani-Becheikh, R1
Winstanley, P1
Adjei, S1
Anemana, S1
Issifou, S3
Mockenhaupt, F1
Owusu-Agyei, S3
Grobusch, MP3
Kremsner, PG3
Macete, E1
Newman, RD3
Slutsker, L5
Gabor, JJ1
Schwarz, NG2
Poetschke, M1
Doernemann, J1
Schuster, K1
Koester, KB1
Profanter, K1
Borchert, LB1
Kurth, F1
Pongratz, P2
Nzenze-Afene, S1
Ngoungou, EB1
Owono-Medang, M1
Lekana-Douki, JB1
Obono-Obiang, G1
Mounanga, M1
Shekalaghe, SA1
ter Braak, R1
Daou, M1
Kavishe, R1
van den Bijllaardt, W1
van den Bosch, S1
Koenderink, JB1
Luty, AJ1
Whitty, CJ1
Drakeley, C2
Sauerwein, RW1
Bousema, T1
Odhiambo, FO1
Hamel, MJ3
Williamson, J1
Lindblade, K1
Peterson, E1
Otieno, P1
Kariuki, S1
Vulule, J1
Msyamboza, K1
Savage, E1
Kazembe, P2
Bojang, KA1
Milligan, PJ3
Conway, DJ1
Sisay-Joof, F1
Jallow, M1
Nwakanma, DC1
Abubakr, I1
Njie, F1
Oduro, AR1
Fryauff, DJ1
Koram, KA1
Rogers, WO1
Anto, F1
Atuguba, F1
Anyorigiya, T1
Ansah, P1
Nkrumah, F1
Conteh, L1
Patouillard, E1
Legood, R1
Gara, SN1
Madaki, AJ1
Thacher, TD1
Aziken, ME1
Akubuo, KK1
Gharoro, EP1
Kapito-Tembo, A1
van Hensbroek, MB1
Phiri, K1
Fitzgerald, M1
Mwapasa, V1
Willey, BA1
Armstrong Schellenberg, JR1
Maokola, W1
Chemba, M1
Maiga, AS1
Diakite, M1
Diawara, A1
Sango, HA1
Coulibaly, CO1
Wilson, NO1
Ceesay, FK1
Obed, SA1
Adjei, AA1
Gyasi, RK1
Rodney, P1
Ndjakani, Y1
Anderson, WA1
Lucchi, NW1
Stiles, JK1
Diakite, OS1
Maiga, OM1
Traoré, BT1
Diallo, M2
Traoré, M2
Ongoiba, A3
Traoré, MS1
Guindo, O2
Karim, DM1
Coulibaly, S1
Bougoudogo, F1
Danis, M1
Konaté, AT2
Yaro, JB1
Ouédraogo, AZ1
Diarra, A2
Gansané, A1
Soulama, I1
Kangoyé, DT1
Kaboré, Y1
Ouédraogo, E1
Ouédraogo, A2
Tiono, AB2
Ouédraogo, IN1
Cousens, S2
Sirima, SB2
Greenwood, BM2
Diallo, DA2
Dicko, A2
Barry, A1
Dicko, M1
Diallo, AI1
Dicko, Y1
Dara, N1
Sidibe, Y1
Santara, G1
Conaré, T1
Taylor, SM1
Hand, CC1
Mwandagalirwa, K1
Messina, JP1
Tshefu, AK1
Atua, B1
Emch, M1
Muwonga, J1
Tine, RC1
Faye, B1
Ndour, CT1
Ndiaye, JL1
Ndiaye, M1
Bassene, C1
Sylla, K1
Ndour, JD1
Gaye, O1
Tutu, EO1
Lawson, B1
Browne, E1
Sorgho, H1
Ouedraogo, JB2
Shaukat, AM1
Gilliams, EA1
Kenefic, LJ1
Laurens, MB1
Dzinjalamala, FK2
Nyirenda, OM1
Thesing, PC1
Jacob, CG1
Molyneux, ME2
Taylor, TE2
Plowe, CV2
Laufer, MK1
Urassa, DP1
Nystrom, L1
Carlsted, A1
Verhoef, H2
West, CE2
Nzyuko, SM1
de Vogel, S1
van der Valk, R1
Wanga, MA1
Kuijsten, A1
Veenemans, J1
Kok, FJ1
Zoungrana, EB1
Guiguemde, TR1
Van Marck, E1
Desai, MR3
Mei, JV1
Kariuki, SK3
Wannemuehler, KA2
Phillips-Howard, PA1
Nahlen, BL2
Kager, PA5
Vulule, JM1
MARCHAL, G1
BILSKI-PASQUIER, G1
CAP, J1
BOCK, HE1
FREY, J1
SCHUBERT, JC1
SCHUBERT, H1
MARTIN, H1
CHANARIN, I1
TENPAS, A1
ABRAHAM, JP1
JACKSON, N1
DAVID, HL1
Kublin, JG1
Kamwendo, DS1
Mukadam, RA1
Chimpeni, P1
Terlouw, DJ1
Pfeiffer, CM1
Shi, YP3
Dhar, R1
Rosen, DH2
Nganda, RY1
Reyburn, H1
Marchant, T1
Kodio, M1
Coulibaly, D1
Keita, AS1
Maiga, B1
Mungai, M1
Parise, ME1
Doumbo, O2
Cusick, SE1
Tielsch, JM1
Ramsan, M1
Jape, JK1
Sazawal, S1
Black, RE1
Stoltzfus, RJ1
Awine, T2
Amponsa-Achiano, K1
Jaffar, S1
Baiden, R1
Lemnge, MM1
Ali, AS1
Malecela, EK1
Sambu, E1
Abdulla, R1
Juma, MS1
Fakih, K1
Abdulla, KH1
Njau, RJ1
Patrick Kachur, S1
Schulden, J1
Goodman, CA1
Kassala, H1
Elling, BF1
Khatib, RA1
Causer, LM1
Mkikima, S1
Abdulla, S1
Bloland, PB2
Mbaye, A2
Richardson, K2
Balajo, B2
Dunyo, S2
Shulman, C4
Milligan, P3
Walraven, G2
Mulenga, M3
Malunga, P1
Bennett, S2
Thuma, P1
Fielding, K2
Kone, M1
Tolo, Y1
Thera, MA1
Sogoba, M1
Fofana, M1
Ouattara, A1
Sissoko, M1
Jansen, HF1
Malunga, F1
Thuma, PE3
Alloueche, A1
Shah, SN1
Smith, EE1
Obonyo, CO2
Kain, KC1
Ayisi, JG2
Otieno, JA1
Steketee, RW1
Taylor, W1
Ekvall, H1
Kaneko, A1
Ter Kuile, F1
Olliaro, P1
Bjorkman, A1
Oloo, AJ1
Bygbjerg, I1
Mockenhaupt, FP2
Reither, K1
Zanger, P1
Roepcke, F1
Saad, E1
Ziniel, P1
Dzisi, SY1
Frempong, M1
Agana-Nsiire, P1
Amoo-Sakyi, F1
Otchwemah, R1
Cramer, JP1
Anemana, SD1
Dietz, E1
Bienzle, U2
Kahigwa, E1
Vountasou, P1
Hommerich, L1
von Oertzen, C1
Bedu-Addo, G1
Holmberg, V1
Acquah, PA1
Eggelte, TA1
Gill, CJ2
Macleod, WB2
Mwanakasale, V2
Chalwe, V2
Mwananyanda, L2
Champo, D2
Mukwamataba, D2
Chilengi, R2
Thea, DM2
Hamer, DH2
Mubikayi, L1
Mulele, CK1
Gabor, J1
Dornemann, J1
Potschke, M1
Oyakhirome, S1
Kiessling, GC1
Necek, M1
Langin, MU1
Klein Klouwenberg, P1
Klopfer, A1
Naumann, B1
Altun, H1
Agnandji, ST1
Goesch, J1
Decker, M1
Salazar, CL1
Supan, C1
Kombila, DU1
Borchert, L1
Koster, KB1
Adegnika, AA1
Glasenapp, Iv1
Ouma, P1
Parise, M1
Otieno, K1
Tarimo, SD1
Nahum, A1
Erhart, A1
Gazard, D1
Agbowai, C1
Van Overmeir, C1
van Loen, H1
Menten, J1
Akogbeto, M1
Coosemans, M1
Dabo, CA1
Saye, R1
Yattara, O1
Diarra, MA1
Sangho, H1
Bougouma, EC1
Nébié, I1
Asa, OO1
Onayade, AA1
Fatusi, AO1
Ijadunola, KT1
Abiona, TC1
Cairns, M1
Gosling, R1
Deroń, Z1
Jabłkowski, M1
Phillips, RE1
Verhoeff, FH1
Masache, P1
Kachale, B1
Van der Kaay, HJ1
Biemba, G2
Gordeuk, VR2
Mabeza, GF2
Weiss, G1
Shulman, CE2
Dorman, EK1
Cutts, F1
Kawuondo, K1
Bulmer, JN1
Peshu, N1
Marsh, K1
Dolmans, DE1
Parry, D1
McLaren, CE1
Okafor, HU1
Nwaiwu, O1
Harrison, KA1
Ibeziako, PA1
Tong, MJ1
Strickland, GT1
Votteri, BA1
Gunning, JJ1
Voller, A1
Hawkey, CM1
Richards, WH1
Ridley, DS1
Canfield, CJ1
Keller, HI1
Cirksena, WJ1
Scheuer-Karpin, R1
Topley, E2

Clinical Trials (25)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy[NCT00811421]5,820 participants (Actual)Interventional2009-09-30Completed
Scaling up the Use of Sulphadoxine-Pyrimethamine for the Preventive Treatment of Malaria in Pregnancy: Results and Lessons on Scalability, Costs and Program From Three Local Government Areas in Sokoto State, Nigeria[NCT02758353]31,493 participants (Actual)Interventional2015-04-30Completed
Aetiology, Prevention and Control of Anaemia in Sub-Saharan Africa - Work Package 2: Efficacy Study: Efficacy of 2 Iron Fortified Porridges and IPT for the Prevention of Anemia in Young Children in Côte d'Ivoire.[NCT01634945]629 participants (Actual)Interventional2012-04-30Completed
Intermittent Preventive Treatment in Schools: a Randomised Controlled Trial of the Impact of IPT on Malaria, Anaemia and Education Amongst Schoolchildren in Western Kenya[NCT00142246]Phase 36,758 participants (Actual)Interventional2005-01-31Completed
Effect of Intermittent Preventive Treatment (IPTp) With Sulfadoxine-Pyrimethamine Plus Insecticide Treated Nets, Delivered Through Antenatal Clinics for the Prevention of Malaria in Mozambican Pregnant Women[NCT00209781]1,028 participants Interventional2003-08-31Active, not recruiting
Efficacy of Sulphadoxine-pyrimethamine and Amodiaquine Alone or in Combination as Intermittent Preventive Treatment in Pregnancy in the Kassena-Nankana District of Ghana: a Randomized Controlled Trial[NCT00146783]Phase 2/Phase 33,642 participants (Actual)Interventional2004-06-30Completed
A Study Of Impact Of Intermittent Preventive Treatment In Children With Amodiaquine Plus Artesunate Versus Sulphadoxine-Pyrimethamine On Hemoglobin Levels And Malaria Morbidity In Hohoe District Of Ghana[NCT00119132]Phase 2/Phase 32,602 participants (Actual)Interventional2005-06-30Completed
Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi[NCT03376217]1,447 participants (Actual)Interventional2017-12-01Completed
Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Zambia[NCT06166498]Phase 3600 participants (Anticipated)Interventional2024-02-15Not yet recruiting
Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Cameroon[NCT06173206]Phase 3900 participants (Anticipated)Interventional2024-03-15Not yet recruiting
A Longitudinal Study Assessing the Infectious Status and Immunity of Mothers and Their Children in Lambaréné, Including Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control and Its Impact on Long-term Health[NCT00167843]Phase 41,189 participants Interventional2002-12-31Completed
Mass-Drug Administration With a Gametocytocidal Drug Combination, a Model for a Transmission Blocking Vaccine[NCT00509015]6,000 participants (Anticipated)Interventional2008-02-29Completed
Evaluation of the Efficacy and Safety of Primaquine for Clearance of Gametocytes in Uncomplicated Falciparum Malaria in Uganda[NCT01365598]Phase 3468 participants (Actual)Interventional2011-12-31Completed
Phase 2a Dose Escalation Study of the Efficacy, Safety, and Pharmacokinetics of Low Dose Primaquine for Gametocytocidal Activity Against P. Falciparum in Sub-Saharan Africa and South East Asia[NCT01743820]Phase 281 participants (Actual)Interventional2013-09-30Completed
Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya[NCT00111163]1,516 participants Interventional2004-03-31Completed
Chemoprophylaxis With Sulfadoxine-pyrimethamine to Prevent Recurrence of Severe Anaemia in Gambian Children Aged 3 Months to 9 Years[NCT00131716]Phase 31,200 participants (Actual)Interventional2003-05-31Completed
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity[NCT05757167]Phase 42,500 participants (Anticipated)Interventional2023-11-06Recruiting
A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children[NCT00738946]6,000 participants (Anticipated)Interventional2008-08-31Completed
Effect of Prenatal Nutritional Supplementation on Birth Outcome in Hounde District, Burkina Faso[NCT00909974]Phase 41,302 participants (Anticipated)Interventional2006-02-28Completed
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial[NCT00206739]Phase 41,070 participants (Actual)Interventional2003-01-31Completed
Evaluation of the Safety and Effectiveness of EPI-linked Malaria Intermittent Chemotherapy and Iron Supplementation[NCT00857077]2,485 participants (Actual)Interventional2000-09-30Completed
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)[NCT04844099]Phase 3723 participants (Actual)Interventional2021-04-09Completed
Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia[NCT00270530]Phase 4454 participants Interventional2002-11-30Completed
A Comparative Assessment of the Efficacy of Fosmidomycin-Clindamycin Versus Sulfadoxine-Pyrimethamine for the Treatment of Children With Uncomplicated Plasmodium Falciparum Malaria[NCT00214643]Phase 3160 participants Interventional2005-06-30Completed
Intermittent Preventive Treatment With Azithromycin-containing Regimens for the Prevention of Malarial Infections and Anaemia and the Control of Sexually Transmitted Infections in Pregnant Women in Papua New Guinea[NCT01136850]Phase 32,793 participants (Actual)Interventional2009-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for pyrimethamine and Anemia

ArticleYear
Recent work concerning anemia in the tropics.
    Seminars in hematology, 1982, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Anemia; Anemia, Hypochromic; Anemia, Megaloblastic; Animals; Child; Child, Presch

1982
Malaria in pregnancy control and pregnancy outcomes: a decade's overview using Ghana's DHIMS II data.
    Malaria journal, 2022, Oct-27, Volume: 21, Issue:1

    Topics: Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Ghana; Humans; Malaria; Pregnancy; P

2022
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    The Cochrane database of systematic reviews, 2022, 02-01, Volume: 2, Issue:2022

    Topics: Anemia; Antimalarials; Birth Weight; Child; Child, Preschool; Dietary Supplements; Female; Folic Aci

2022
Mefloquine for preventing malaria in pregnant women.
    The Cochrane database of systematic reviews, 2018, 11-14, Volume: 11

    Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Hum

2018
A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013, Volume: 121, Issue:2

    Topics: Africa South of the Sahara; Anemia; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Bi

2013
Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    The Lancet. Global health, 2015, Volume: 3, Issue:3

    Topics: Africa South of the Sahara; Anemia; Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female;

2015
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Lancet (London, England), 2009, Oct-31, Volume: 374, Issue:9700

    Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations;

2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Lancet (London, England), 2009, Oct-31, Volume: 374, Issue:9700

    Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations;

2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Lancet (London, England), 2009, Oct-31, Volume: 374, Issue:9700

    Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations;

2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Lancet (London, England), 2009, Oct-31, Volume: 374, Issue:9700

    Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations;

2009
Malaria in pregnancy: its relevance to safe-motherhood programmes.
    Annals of tropical medicine and parasitology, 1999, Volume: 93 Suppl 1

    Topics: Anemia; Antimalarials; Female; Health Policy; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complicat

1999

Trials

63 trials available for pyrimethamine and Anemia

ArticleYear
Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial.
    The American journal of tropical medicine and hygiene, 2022, 10-12, Volume: 107, Issue:4

    Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy

2022
Effectiveness of Intermittent Screening and Treatment of Malaria in Pregnancy on Maternal and Birth Outcomes in Selected Districts in Rwanda: A Cluster Randomized Controlled Trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 07-05, Volume: 77, Issue:1

    Topics: Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Pl

2023
Improving coverage of antenatal iron and folic acid supplementation and malaria prophylaxis through targeted information and home deliveries in Côte d'Ivoire: a cluster randomised controlled trial.
    BMJ global health, 2023, Volume: 8, Issue:4

    Topics: Adolescent; Anemia; Cote d'Ivoire; Dietary Supplements; Drug Combinations; Female; Folic Acid; Human

2023
Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.
    Malaria journal, 2019, Sep-02, Volume: 18, Issue:1

    Topics: Adult; Anemia; Anti-Bacterial Agents; Antimalarials; Artemisinins; Asymptomatic Infections; Azithrom

2019
Blood oxidative stress markers and Plasmodium falciparum malaria in non-immune African children.
    British journal of haematology, 2014, Volume: 164, Issue:3

    Topics: Aldehydes; Anemia; Antigens, Protozoan; Antimalarials; Artemisinins; Biomarkers; Child, Preschool; D

2014
Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Malaria journal, 2010, Nov-12, Volume: 9

    Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Humans; Infant, L

2010
Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
    The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:2

    Topics: Anemia; Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria;

2015
The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
    Malaria journal, 2015, Sep-17, Volume: 14

    Topics: Amodiaquine; Anemia; Antimalarials; Child, Preschool; Cote d'Ivoire; Diphosphates; Drug Combinations

2015
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
    Malaria journal, 2016, Apr-14, Volume: 15

    Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders;

2016
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:3

    Topics: Adolescent; Anemia; Antimalarials; Chemoprevention; Child; Child, Preschool; Democratic Republic of

2017
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2008, Jul-12, Volume: 372, Issue:9633

    Topics: Adolescent; Amodiaquine; Anemia; Animals; Antimalarials; Child; Child, Preschool; Cluster Analysis;

2008
Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
    HIV medicine, 2008, Volume: 9, Issue:9

    Topics: Adult; Anemia; Anti-HIV Agents; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; HIV

2008
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    The Journal of infectious diseases, 2008, Oct-15, Volume: 198, Issue:8

    Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Comb

2008
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
    PloS one, 2008, Volume: 3, Issue:12

    Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; G

2008
Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:2

    Topics: Adult; Anemia; Animals; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans

2009
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.
    Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:7

    Topics: Adolescent; Anemia; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; F

2009
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.
    The Journal of infectious diseases, 2009, Dec-01, Volume: 200, Issue:11

    Topics: Anemia; Antimalarials; Child, Preschool; Cohort Studies; Double-Blind Method; Drug Administration Sc

2009
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru

2010
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.
    PloS one, 2010, Apr-02, Volume: 5, Issue:4

    Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Dapsone; Double-Blind Method; Drug Combinations; Hu

2010
Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.
    PloS one, 2010, Jun-21, Volume: 5, Issue:6

    Topics: Anemia; Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug-Related Side Effects and Ad

2010
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
    PloS one, 2010, Aug-17, Volume: 5, Issue:8

    Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Cost-Benefit Analysi

2010
A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria.
    The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:4

    Topics: Anemia; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination;

2010
Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.
    Malaria journal, 2011, Feb-14, Volume: 10

    Topics: Anemia; Antimalarials; Comorbidity; Drug Administration Schedule; Drug Combinations; Female; Humans;

2011
[Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
    Le Mali medical, 2010, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Endemic D

2010
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Aug-01, Volume: 53, Issue:3

    Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Drug Combinations; Female; Humans; Infant

2011
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Burkina Faso; Child, Preschool; Double-Blind Method

2011
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Child, Preschool; Drug Administration Schedule; Dru

2011
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
    Malaria journal, 2011, Dec-13, Volume: 10

    Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; C

2011
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
    Malaria journal, 2012, Mar-16, Volume: 11

    Topics: Adult; Anemia; Antimalarials; Burkina Faso; Drug Administration Schedule; Drug Combinations; Female;

2012
Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial.
    East African journal of public health, 2011, Volume: 8, Issue:3

    Topics: Adult; Albendazole; Anemia; Anemia, Iron-Deficiency; Anthelmintics; Antimalarials; Cluster Analysis;

2011
Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial.
    Lancet (London, England), 2002, Sep-21, Volume: 360, Issue:9337

    Topics: Anemia; Anthropometry; Antimalarials; Double-Blind Method; Drug Combinations; Female; Hemoglobins; H

2002
Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
    Tropical medicine & international health : TM & IH, 2002, Volume: 7, Issue:11

    Topics: Anemia; Animals; Antimalarials; Burkina Faso; Child, Preschool; Chloroquine; Drug Combinations; Drug

2002
Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya.
    The Journal of infectious diseases, 2003, Feb-15, Volume: 187, Issue:4

    Topics: Anemia; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female;

2003
Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya.
    The American journal of clinical nutrition, 2004, Volume: 79, Issue:3

    Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Disease Susceptibility; Double-Blind M

2004
Daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western Kenya.
    The Journal of nutrition, 2004, Volume: 134, Issue:5

    Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Drug Administration Schedule; Drug Com

2004
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali.
    The Journal of infectious diseases, 2005, Jan-01, Volume: 191, Issue:1

    Topics: Abortion, Spontaneous; Adolescent; Adult; Anemia; Birth Weight; Chemoprevention; Chloroquine; Drug A

2005
Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children.
    The American journal of clinical nutrition, 2005, Volume: 82, Issue:2

    Topics: Anemia; Antimalarials; C-Reactive Protein; Child, Preschool; Drug Combinations; Erythropoiesis; Eryt

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    BMJ (Clinical research ed.), 2005, Oct-01, Volume: 331, Issue:7519

    Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc

2005
Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
    The American journal of tropical medicine and hygiene, 2005, Volume: 73, Issue:4

    Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; H

2005
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    The American journal of tropical medicine and hygiene, 2006, Volume: 74, Issue:6

    Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Dietary Supplements; Drug Combinations; Female; F

2006
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
    The American journal of tropical medicine and hygiene, 2006, Volume: 74, Issue:6

    Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid;

2006
A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
    Tropical medicine & international health : TM & IH, 2006, Volume: 11, Issue:7

    Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Gambia; Gra

2006
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    The American journal of tropical medicine and hygiene, 2006, Volume: 75, Issue:4

    Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child

2006
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
    Tropical medicine & international health : TM & IH, 2006, Volume: 11, Issue:11

    Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations;

2006
Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
    Annals of tropical medicine and parasitology, 2007, Volume: 101, Issue:4

    Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Female; Humans

2007
Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2008, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Anemia; Antimalarials; Case-Control Studies; Community Health Workers; Drug Admin

2008
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem

2007
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem

2007
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem

2007
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem

2007
Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation.
    PLoS medicine, 2007, Jul-31, Volume: 4, Issue:7

    Topics: Age Factors; Anemia; Animals; Antigens, Protozoan; Child, Preschool; Dapsone; Drug Therapy, Combinat

2007
Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Meth

2007
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Meth

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female;

2007
Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya.
    Tropical medicine & international health : TM & IH, 2007, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Humans; Ins

2007
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
    Malaria journal, 2007, Dec-21, Volume: 6

    Topics: Analysis of Variance; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Presch

2007
[Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali].
    Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:5

    Topics: Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infa

2007
[Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso].
    Medecine et maladies infectieuses, 2008, Volume: 38, Issue:4

    Topics: Adult; Anemia; Antimalarials; Burkina Faso; Chloroquine; Drug Therapy, Combination; Female; Humans;

2008
Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women.
    Maternal and child health journal, 2008, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Female; Humans; Malaria; N

2008
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana.
    PloS one, 2008, May-21, Volume: 3, Issue:5

    Topics: Anemia; Drug Administration Schedule; Drug Combinations; Ghana; Humans; Infant; Malaria; Placebos; P

2008
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
    Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153

    Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C

1999
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
    Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153

    Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C

1999
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
    Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153

    Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C

1999
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
    Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153

    Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C

1999
A prospective study of combination antimalarial therapy and of anaemia in Zambian children with cerebral malaria.
    Annals of tropical medicine and parasitology, 1999, Volume: 93, Issue:5

    Topics: Anemia; Antimalarials; Child; Child, Preschool; Drug Therapy, Combination; Follow-Up Studies; Humans

1999
Anemia of persistent malarial parasitemia in Nigerian children.
    Journal of tropical pediatrics, 2001, Volume: 47, Issue:5

    Topics: Anemia; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Hu

2001
Supplemental folates in the therapy of Plasmodium falciparum malaria.
    JAMA, 1970, Dec-28, Volume: 214, Issue:13

    Topics: Administration, Oral; Anemia; Antimalarials; Blood Platelets; Chloroquine; Clinical Trials as Topic;

1970
Erythrokinetics during treatment of acute falciparum malaria.
    Military medicine, 1971, Volume: 136, Issue:4

    Topics: Adult; Anemia; Clinical Trials as Topic; Erythropoiesis; Humans; Leucovorin; Malaria; Male; Military

1971
Common anaemia in rural Gambia. I. Hookworm anaemia among men.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1968, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Anemia; Folic Acid; Folic Acid Deficiency; Gambia; Hemoglobins; Hookworm Infectio

1968

Other Studies

50 other studies available for pyrimethamine and Anemia

ArticleYear
Prevalence and risk factors of malaria and anaemia and the impact of preventive methods among pregnant women: A case study at the Akatsi South District in Ghana.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Humans; Malaria; P

2022
High burden of asymptomatic malaria and anaemia despite high adherence to malaria control measures: a cross-sectional study among pregnant women across two seasons in a malaria-endemic setting in Ghana.
    Infection, 2023, Volume: 51, Issue:6

    Topics: Anemia; Antimalarials; Cross-Sectional Studies; Female; Ghana; Humans; Infant, Newborn; Malaria; Mal

2023
Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
    PloS one, 2021, Volume: 16, Issue:4

    Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Educational Status; Female

2021
High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin.
    Tropical medicine & international health : TM & IH, 2018, Volume: 23, Issue:6

    Topics: Anemia; Benin; Cohort Studies; Dietary Supplements; Drug Combinations; Female; Folic Acid; Humans; M

2018
Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    BMC pregnancy and childbirth, 2019, Jul-08, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans

2019
[Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali].
    Bulletin de la Societe de pathologie exotique (1990), 2013, Volume: 106, Issue:3

    Topics: Adolescent; Adult; Anemia; Chloroquine; Delivery, Obstetric; Drug Combinations; Drug Resistance; Fem

2013
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Tropical medicine & international health : TM & IH, 2014, Volume: 19, Issue:9

    Topics: Adult; Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Low Birth Wei

2014
Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
    BMC infectious diseases, 2014, Nov-19, Volume: 14

    Topics: Adolescent; Adult; Age Factors; Anemia; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug C

2014
Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
    Malaria journal, 2016, Mar-17, Volume: 15

    Topics: Adolescent; Adult; Anemia; Antimalarials; Blood; Cameroon; Chemoprevention; Cross-Sectional Studies;

2016
Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2016, Volume: 110, Issue:6

    Topics: Adult; Anemia; Antimalarials; Birth Weight; Cities; Cross-Sectional Studies; Drug Combinations; Fema

2016
Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
    Malaria journal, 2017, 01-23, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Hemoglobins; Huma

2017
Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008, Volume: 102, Issue:7

    Topics: Adolescent; Anemia; Animals; Antimalarials; Community Health Services; Cost-Benefit Analysis; Drug C

2008
Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:1

    Topics: Anemia; Antimalarials; Child, Preschool; Delivery of Health Care; Female; Health Knowledge, Attitude

2009
Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya.
    Malaria journal, 2008, Sep-30, Volume: 7

    Topics: Anemia; Antimalarials; Chemoprevention; Communicable Disease Control; Cost-Benefit Analysis; Drug Co

2008
Intermittent preventive treatment with antimalarial drugs.
    Lancet (London, England), 2009, Jan-03, Volume: 373, Issue:9657

    Topics: Amodiaquine; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Infant;

2009
Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
    Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Anemia; Antimalarials; Birth Weight; Community Health Services; Drug Combinations

2009
Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.
    The American journal of tropical medicine and hygiene, 2010, Volume: 82, Issue:2

    Topics: Adolescent; Adult; Age Distribution; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinatio

2010
Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements.
    Acta obstetricia et gynecologica Scandinavica, 2010, Volume: 89, Issue:8

    Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Delivery, Obstetric; Drug Combina

2010
Sulfadoxine-pyrimethamine-based intermittent preventive treatment, bed net use, and antenatal care during pregnancy: demographic trends and impact on the health of newborns in the Kassena Nankana District, northeastern Ghana.
    The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:1

    Topics: Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; F

2010
Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 112, Issue:1

    Topics: Adult; Anemia; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Infant, Low Birth W

2011
Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
    The Journal of infectious diseases, 2011, Feb-15, Volume: 203, Issue:4

    Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combination

2011
Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
    The American journal of tropical medicine and hygiene, 2011, Volume: 85, Issue:1

    Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pre

2011
Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.
    The Journal of infectious diseases, 2011, Dec-01, Volume: 204, Issue:11

    Topics: Anemia; Antimalarials; Birth Weight; Cross-Sectional Studies; Democratic Republic of the Congo; Drug

2011
The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
    Malaria journal, 2011, Dec-29, Volume: 10

    Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinatio

2011
Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment.
    Malaria journal, 2012, Jun-18, Volume: 11

    Topics: Anemia; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Fever;

2012
Anaemia in African children: malaria or iron deficiency?
    Lancet (London, England), 2003, Jun-28, Volume: 361, Issue:9376

    Topics: Africa; Anemia; Anemia, Iron-Deficiency; Antimalarials; Child, Preschool; Drug Combinations; Humans;

2003
[Severe anemia caused by pyrimethamine therapy of polycythemia].
    Le Sang, 1958, Volume: 29, Issue:3

    Topics: Anemia; Antimalarials; Humans; Polycythemia; Polycythemia Vera; Pyrimethamine

1958
[Polycythemia vera in an 11-year-old child. Bone marrow depression after daraprim treatment].
    Ceskoslovenska pediatrie, 1961, Volume: 16

    Topics: Anemia; Anemia, Aplastic; Antimalarials; Bone Marrow; Child; Depression; Humans; Infant; Pancytopeni

1961
[Megaloblastic anemias with peripheral micro-and macroplania in daraprim therapy of polycythemia vera].
    Arztliche Wochenschrift, 1960, Mar-04, Volume: 15

    Topics: Anemia; Anemia, Megaloblastic; Antimalarials; Polycythemia Vera; Pyrimethamine; Tracheophyta

1960
[A COMPARISON OF MEGALOBLASTIC MARROW CHANGES AFTER DARAPRIM THERAPY AND IN PERNICIOUS ANEMIA].
    Medizinische Klinik, 1964, Mar-13, Volume: 59

    Topics: Anemia; Anemia, Aplastic; Anemia, Megaloblastic; Anemia, Pernicious; Blood Cell Count; Bone Marrow;

1964
STUDIES IN DRUG-INDUCED MEGALOBLASTIC ANAEMIA.
    Scandinavian journal of haematology, 1964, Volume: 1

    Topics: Anemia; Anemia, Macrocytic; Anemia, Megaloblastic; Blood; Blood Cell Count; Geriatrics; Glutamates;

1964
HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS.
    The American journal of the medical sciences, 1965, Volume: 249

    Topics: Anemia; Anemia, Macrocytic; Blood Platelets; Drug Therapy; Folic Acid; Hemoglobinometry; Humans; Leu

1965
SOME EFFECTS OF PROCAINE PENICILLIN ON THE PYRIMETHAMINE-TREATED CHICK WITH SPECIAL REFERENCE TO ITS EFFECT ON OVIDUCT GROWTH INHIBITION.
    Research in veterinary science, 1965, Volume: 6

    Topics: Anemia; Anemia, Macrocytic; Animals; Chickens; DNA; Fallopian Tubes; Female; Organ Size; Oviducts; P

1965
SOME FEATURES OF MALARIA IN DILI, PORTUGUESE TIMOR, DURING 1963-64.
    Annals of tropical medicine and parasitology, 1965, Volume: 59

    Topics: Amodiaquine; Anemia; Chloroquine; Clinical Laboratory Techniques; Drug Therapy; Epidemiology; Humans

1965
Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.
    BMJ (Clinical research ed.), 2004, Mar-06, Volume: 328, Issue:7439

    Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Eva

2004
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania.
    Malaria journal, 2004, Nov-12, Volume: 3

    Topics: Adult; Age Factors; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Educational Status

2004
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
    Tropical medicine & international health : TM & IH, 2006, Volume: 11, Issue:4

    Topics: Adult; Amodiaquine; Analgesics, Non-Narcotic; Anemia; Antimalarials; Child, Preschool; Drug Combinat

2006
HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
    The Journal of infectious diseases, 2006, Dec-01, Volume: 194, Issue:11

    Topics: Adult; Anemia; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; Fever; HIV Infections

2006
Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya.
    Tropical medicine & international health : TM & IH, 2007, Volume: 12, Issue:3

    Topics: Adult; Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid; Hema

2007
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
    Malaria journal, 2007, Nov-08, Volume: 6

    Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Birth Weight; Chemoprevention; Drug Administratio

2007
Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
    East African journal of public health, 2007, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans

2007
[Side effects of toxoplasmosis treatment].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1980, Jun-09, Volume: 35, Issue:23

    Topics: Adolescent; Adult; Anemia; Antiprotozoal Agents; Child; Child, Preschool; Drug Eruptions; Dyspepsia;

1980
Management of Plasmodium falciparum malaria.
    The Medical journal of Australia, 1984, Oct-13, Volume: 141, Issue:8

    Topics: Amodiaquine; Anemia; Antimalarials; Brain Diseases; Chloroquine; Drug Resistance; Female; Humans; Hy

1984
Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi.
    Annals of tropical medicine and parasitology, 1997, Volume: 91, Issue:2

    Topics: Anemia; Antimalarials; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Hemoglobins;

1997
Prolonged macrophage activation and persistent anaemia in children with complicated malaria.
    Tropical medicine & international health : TM & IH, 1998, Volume: 3, Issue:1

    Topics: Analysis of Variance; Anemia; Antimalarials; Child, Preschool; Deferoxamine; Drug Therapy, Combinati

1998
Intermittent malaria treatment as a component of the EPI (Expanded Programme on Immunization) schedule in Africa.
    Releve epidemiologique hebdomadaire, 2002, Mar-15, Volume: 77, Issue:11

    Topics: Africa; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Immunization

2002
Maternal anaemia and fetal birthweight.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1973, Volume: 80, Issue:9

    Topics: Anemia; Anemia, Sickle Cell; Birth Weight; Blood Transfusion; Body Height; Chloroquine; Embryonic an

1973
Human malaria (Plasmodium falciparum) in owl monkeys (Aotus trivirgatus).
    The Journal of tropical medicine and hygiene, 1969, Volume: 72, Issue:7

    Topics: Anemia; Animals; Antimalarials; Blood Coagulation; Haplorhini; Malaria; Myocardium; Plasmodium falci

1969
[Distrubed granulocytopoiesis following administration of various drugs].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1969, Nov-15, Volume: 24, Issue:22

    Topics: Adult; Aged; Agranulocytosis; Anemia; Antimetabolites; Bone Marrow Examination; Drug-Related Side Ef

1969
Common anaemia in rural Gambia. 3. A spontaneously remitting anaemia possibly precipitated by malarial parasitaemia.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1968, Volume: 62, Issue:5

    Topics: Adolescent; Anemia; Child; Child, Preschool; Female; Gambia; Hemoglobins; Humans; Infant; Infant, Ne

1968